The role of FasR/FasL system in pathogenesis of myeloprolyferative neoplasms

Myeloproliferative neoplasms (MPN) are hematological malignancies characterized by uncontrolled cell proliferation and impaired apoptosis. The FasR/FasL system is involved in the control of apoptosis in different cell types. Here we have investigated the role of FasR/FasL in the pathogenesis of MPNs...

Full description

Bibliographic Details
Main Authors: Spasovski Vesna, Tosić Natasa, Kostić Tatjana, Zukić Branka, Stojiljković Maja, Čolović Milica, Pavlović Sonja
Format: Article
Language:English
Published: University of Belgrade, University of Novi Sad 2010-01-01
Series:Archives of Biological Sciences
Subjects:
Online Access:http://www.doiserbia.nb.rs/img/doi/0354-4664/2010/0354-46641002223S.pdf
id doaj-69d5626d6ea44068ba6e07345d96fcbe
record_format Article
spelling doaj-69d5626d6ea44068ba6e07345d96fcbe2020-11-24T23:02:12ZengUniversity of Belgrade, University of Novi SadArchives of Biological Sciences0354-46642010-01-0162222323010.2298/ABS1002223SThe role of FasR/FasL system in pathogenesis of myeloprolyferative neoplasmsSpasovski VesnaTosić NatasaKostić TatjanaZukić BrankaStojiljković MajaČolović MilicaPavlović SonjaMyeloproliferative neoplasms (MPN) are hematological malignancies characterized by uncontrolled cell proliferation and impaired apoptosis. The FasR/FasL system is involved in the control of apoptosis in different cell types. Here we have investigated the role of FasR/FasL in the pathogenesis of MPNs. We compared FasR/FasL expression between MPN patients (24) and healthy individuals using the real-time PCR assay. We found an increase of FasR expression in MPN patients. No difference was detected in FasL expression. Mutation V617F in the JAK2 gene, a hallmark of MPN, was detected in 13/24 patients. We found that neither FasR nor FasL expression were related to the presence of JAK2 V617F mutation. http://www.doiserbia.nb.rs/img/doi/0354-4664/2010/0354-46641002223S.pdfMyeloproliferative neoplasmsFasR/FasLJAK2 V617F mutation
collection DOAJ
language English
format Article
sources DOAJ
author Spasovski Vesna
Tosić Natasa
Kostić Tatjana
Zukić Branka
Stojiljković Maja
Čolović Milica
Pavlović Sonja
spellingShingle Spasovski Vesna
Tosić Natasa
Kostić Tatjana
Zukić Branka
Stojiljković Maja
Čolović Milica
Pavlović Sonja
The role of FasR/FasL system in pathogenesis of myeloprolyferative neoplasms
Archives of Biological Sciences
Myeloproliferative neoplasms
FasR/FasL
JAK2 V617F mutation
author_facet Spasovski Vesna
Tosić Natasa
Kostić Tatjana
Zukić Branka
Stojiljković Maja
Čolović Milica
Pavlović Sonja
author_sort Spasovski Vesna
title The role of FasR/FasL system in pathogenesis of myeloprolyferative neoplasms
title_short The role of FasR/FasL system in pathogenesis of myeloprolyferative neoplasms
title_full The role of FasR/FasL system in pathogenesis of myeloprolyferative neoplasms
title_fullStr The role of FasR/FasL system in pathogenesis of myeloprolyferative neoplasms
title_full_unstemmed The role of FasR/FasL system in pathogenesis of myeloprolyferative neoplasms
title_sort role of fasr/fasl system in pathogenesis of myeloprolyferative neoplasms
publisher University of Belgrade, University of Novi Sad
series Archives of Biological Sciences
issn 0354-4664
publishDate 2010-01-01
description Myeloproliferative neoplasms (MPN) are hematological malignancies characterized by uncontrolled cell proliferation and impaired apoptosis. The FasR/FasL system is involved in the control of apoptosis in different cell types. Here we have investigated the role of FasR/FasL in the pathogenesis of MPNs. We compared FasR/FasL expression between MPN patients (24) and healthy individuals using the real-time PCR assay. We found an increase of FasR expression in MPN patients. No difference was detected in FasL expression. Mutation V617F in the JAK2 gene, a hallmark of MPN, was detected in 13/24 patients. We found that neither FasR nor FasL expression were related to the presence of JAK2 V617F mutation.
topic Myeloproliferative neoplasms
FasR/FasL
JAK2 V617F mutation
url http://www.doiserbia.nb.rs/img/doi/0354-4664/2010/0354-46641002223S.pdf
work_keys_str_mv AT spasovskivesna theroleoffasrfaslsysteminpathogenesisofmyeloprolyferativeneoplasms
AT tosicnatasa theroleoffasrfaslsysteminpathogenesisofmyeloprolyferativeneoplasms
AT kostictatjana theroleoffasrfaslsysteminpathogenesisofmyeloprolyferativeneoplasms
AT zukicbranka theroleoffasrfaslsysteminpathogenesisofmyeloprolyferativeneoplasms
AT stojiljkovicmaja theroleoffasrfaslsysteminpathogenesisofmyeloprolyferativeneoplasms
AT colovicmilica theroleoffasrfaslsysteminpathogenesisofmyeloprolyferativeneoplasms
AT pavlovicsonja theroleoffasrfaslsysteminpathogenesisofmyeloprolyferativeneoplasms
AT spasovskivesna roleoffasrfaslsysteminpathogenesisofmyeloprolyferativeneoplasms
AT tosicnatasa roleoffasrfaslsysteminpathogenesisofmyeloprolyferativeneoplasms
AT kostictatjana roleoffasrfaslsysteminpathogenesisofmyeloprolyferativeneoplasms
AT zukicbranka roleoffasrfaslsysteminpathogenesisofmyeloprolyferativeneoplasms
AT stojiljkovicmaja roleoffasrfaslsysteminpathogenesisofmyeloprolyferativeneoplasms
AT colovicmilica roleoffasrfaslsysteminpathogenesisofmyeloprolyferativeneoplasms
AT pavlovicsonja roleoffasrfaslsysteminpathogenesisofmyeloprolyferativeneoplasms
_version_ 1725636858165067776